Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma donates 50,000 Euros to support construction of the Albert Einstein Discovery Center in Ulm
September 22, 2021 07:00 ET | Rentschler Biopharma SE
LAUPHEIM, Germany and ULM, Germany, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, is...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma breaks ground at new U.S. production site in greater Boston
August 12, 2021 08:00 ET | Rentschler Biopharma SE
New facility, adjacent to existing Milford, MA site, to significantly expand cGMP manufacturing capacity, accelerating clinical and commercial supply of essential biopharmaceuticalsSite will employ...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma appoints Dr. Martin Kessler as Chief Executive Officer of U.S. Subsidiary and as Senior Vice President Transformation
March 31, 2021 04:00 ET | Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass., March 31, 2021 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals,...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma and Leukocare extend service offering with joint U.S. site
March 22, 2021 05:00 ET | Rentschler Biopharma SE
Leukocare joins Rentschler Biopharma in the U.S., facilitating integrated alliance capabilities and enhanced service for North American clientsClient-focused approach and integration of best-in-class...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma establishes Center of Excellence for cell and gene therapy in the UK
February 11, 2021 04:10 ET | Rentschler Biopharma SE
New enterprise, Rentschler ATMP Ltd., is part of continuous innovation at Rentschler Biopharma and supports ongoing strategic international expansionCenter of Excellence to address the gap in capacity...
Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma to build new cell and gene therapy capabilities in the UK Rentschler Biopharma will establish their ATMP development and manufacturing capabilities at the Cell and Gene Therapy Catapult facility in StevenageAgreement confirms UK’s global attractiveness for...
NEU 2020_Logo_Leukocare_1400x360px_300_rgb.jpg
Leukocare starts operations in the US and opens development laboratories and offices in Boston Metropolitan Area
January 11, 2021 08:00 ET | LEUKOCARE AG
MARTINSRIED, Germany and MUNICH, Germany and MILFORD, Mass., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Germany-based formulation development specialist Leukocare opens US presence to support local...